NOVOMIX 30 FLEXPEN

Novomix 30 1001U/ml Flexpen 3 ml is a combination of rapid-acting human insulin and longer-acting
insulin analogue to treat diabetes mellitus in children (above 2 years of age) and adults. It maintains
blood sugar levels in adults and children. Diabetes mellitus is a condition that affects the way your
body processes glucose. In Diabetes Mellitus Type 1, the body does not make enough insulin to
control blood sugar levels. In Diabetes Mellitus type 2, either the body stops producing enough insulin
(the hormone which helps to decrease sugar levels in the blood), or there is resistance to insulin
action. As a result, insulin is produced in large amounts, but it cannot act on the organs of the body.
Novomix 30 1001U/ml Flexpen 3 ml is a combination medicine that contains insulin aspart (rapid-
acting), and the other is insulin aspart protamine (longer-acting). Insulin aspart has a fast onset of
action, and insulin aspart protamine has a prolonged duration of action. Together, they ensure rapid
and stable sugar control by enabling the reuptake of sugar in muscle and fat cells and decreasing
sugar production in the liver.
Take Novomix 30 1001U/ml Flexpen 3 ml as prescribed by your doctor. You are advised to take
Novomix 30 10011J/ml Flexpen 3 ml for as long as your doctor has prescribed it for you, depending
on your medical conditions. You may experience weight gain, injection site allergic reaction, rash,
lipodystrophy (skin thickening or pits at the injection site), hypoglycaemia (low blood glucose level),
and itching. Most of these side effects of Novomix 30 1001U/ml Flexpen 3 ml do not require medical
attention and gradually resolve over time. However, if the side effects are persistent, reach out to your
doctor.